Sachin Baban Gavhane

This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Glenmark Pharmaceuticals S.a., Glenmark Life Sciences Limited, Glenmark Pharmaceuticals Limited. Active years: 2010-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sachin Baban Gavhane. Retrieved from https://idiyas.com/inventor/sachin-baban-gavhane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 16.7

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 6.1

ph-index = 1

Location History:

Ahmednagar, IN (2010)
Dombivli, IN (2016)
Thane, IN (2016 - 2019)
Maharashtra, IN (2018 - 2019)

Company Filing History:

3 out of 65

Glenmark Pharmaceuticals S.a.

patents

1 out of 6

Glenmark Life Sciences Limited

patents

1 out of 33

Glenmark Pharmaceuticals Limited

Years Active: 2010-2019

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10494342 - Process for the preparation of apremilast (2019-12-03),

2. 10457649 - Polymorphs of a mPGES-1 inhibiting triazolone compound (2019-10-29),

3. 10112914 - Polymorphs of a mPGES-1 inhibiting triazolone compound (2018-10-30),

4. 9499475 - Process for the preparation of arformoterol or salt thereof (2016-11-22),

5. 9458173 - Amides of 2-amino-4-arylthiazole compounds and their salts (2016-10-04),

6. 7678912 - Process for preparation of 4-amino-1-isobutyl-1H-imidazo[4,5-C]-quinoline (Imiquimod) (2010-03-16),

Title: Innovations by Sachin Baban Gavhane

Introduction

Sachin Baban Gavhane is a notable inventor based in Thane, India. He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work focuses on innovative processes and compounds that have the potential to impact medical treatments.

Latest Patents

Gavhane's latest patents include a process for the preparation of apremilast, which relates to a method for synthesizing this important pharmaceutical compound. Additionally, he has developed polymorphs of a mPGES-1 inhibiting triazolone compound, which showcases solid-state forms that exhibit enzyme inhibition activity. This compound, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl)pivalamide, represents a significant advancement in the field.

Career Highlights

Throughout his career, Gavhane has worked with prominent companies such as Glenmark Pharmaceuticals S.A. and Glenmark Life Sciences Limited. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects.

Collaborations

Gavhane has collaborated with talented individuals in his field, including Suresh Mahadev Kadam and Sandeep Bandu Khandagale. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Sachin Baban Gavhane's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and innovations.

Profile summary based on public USPTO records.